Study of NGR-hTNF in Combination With Cisplatin in Solid Tumor

NCT00483093 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: NGR-hTNF
DRUG: Cisplatin

Sponsor

AGC Biologics S.p.A.